Clozapine, neuroleptic malignant syndrome, and pancerebellar syndrome.
Brown
T M
TM
Department of Psychiatry and Neurology, Tulane University Medical Center, Gautier, MS 39553, USA. drugeffects@ibm.net
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002526:Cerebellar Diseases / Q000139:chemically induced* / Q000175:diagnosis; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007326:Institutionalization; D008607:Intellectual Disability / Q000188:drug therapy*; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*; D009460:Neurologic Examination / Q000187:drug effects; D011595:Psychomotor Agitation / Q000188:drug therapy*
D014150:Antipsychotic Agents; D003024:Clozapine